Board of Directors

We have a well-structured, experienced board comprising of an executive chairman, one non-executive and three executive directors.


Paul Fitzsimon

Paul Fitzsimons Chairman

Paul joined as Chairman in 2015 and has 23 years’ experience in the private equity sector. Paul acts as an adviser to the Allocate Software board. Since joining Apax Partners in 1992, Paul has spent his career as both an investor in and a board member of private equity companies. He retired from Apax Partners in 2010 as a member of the Investment Committee and now advises Hg Capital, the majority shareholder of Allocate Software, as well as holding a number of investments in private companies


Dr. Sati Sian Chief Executive Officer

Sati joined as Chief Executive Officer (CEO) in September 2015. Sati brings over 30 years of global experience in the healthcare information, software and services sector. Sati joined Allocate from IMS Health where he held a variety of roles, most recently as Senior VP for Global Technology and Operations leading a global team of over 6,000 people responsible for operations, product development, services and technology. His prior roles included President of IMS’s China operations, General Manager of IMS’s Global Consumer Health business, and managing IMS Health’s Consulting and Services business in Europe, the Middle East and Africa, leading it through an aggressive growth phase. Dr. Sian earned a Ph.D. in Information Technology from Imperial College, and holds an M.B.A. in Strategic Management.


Robin Wooldridge  Chief Financial Officer

Robin joined as Chief Financial Officer (CFO) in 2015.  Previously, he was CFO of OB10 Limited, the leading global electronic invoicing network, which was acquired by Tungsten Corporation plc.  Prior to this, Robin was Finance Director of market research company TNS UK, within the WPP group, and of travel loyalty business Air Miles (now Avios), a subsidiary of British Airways.  Robin is a Chartered Accountant who qualified with KPMG in London.

Allen Swann

Allen Swann Business Development Director

Allen joined as Business Development Director in June 2008, having previously acted as an adviser to the company. Prior to his appointment, Allen served as International President for Chordiant Inc, International President of Prime Response Inc and was a founder member of Oracle UK, where he served as Sales Director both direct and non-direct for 12 years. Allen is also Non-Executive Chairman of CopperEye Limited and a non-executive director of Chordiant Inc.

 Dr Graham Rich_1

Dr. Graham Rich Non-Executive Director

Dr Graham Rich joined as a Non-Executive Director in December 2013. Dr Rich is an experienced former chief executive of NHS hospitals including a Foundation Trust and a primary care trust (PCT) as well formerly holding a position as Director of Commissioning. He is currently a co-founder of CareTechnica Ltd, a company focusing on the commercialization of medical technology. He has also previously worked on national policy formulation and implementation at the Department of Health. His international experience includes health policy formulation and management consulting in the USA. He has particular interest in patient empowerment, the use of IT in healthcare, improved transparency of outcomes and patient satisfaction to drive performance improvement. His specialities include quality improvement, leadership development, value based healthcare and patient safety.

LinkedIn Twitter Contact us